These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21044870)

  • 21. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
    Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
    Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes.
    Skoglund C; Chéramy M; Casas R; Ludvigsson J; Hampe CS
    Pediatr Diabetes; 2012 May; 13(3):244-50. PubMed ID: 21848927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial.
    Elding Larsson H; Lundgren M; Jonsdottir B; Cuthbertson D; Krischer J;
    Pediatr Diabetes; 2018 May; 19(3):410-419. PubMed ID: 29171140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
    Khan S; Burt DJ; Ralph C; Thistlethwaite FC; Hawkins RE; Elkord E
    Clin Immunol; 2011 Jan; 138(1):85-96. PubMed ID: 21056008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.
    Horie S; Sugita S; Futagami Y; Yamada Y; Mochizuki M
    Clin Immunol; 2010 Jul; 136(1):83-95. PubMed ID: 20350837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.
    Ludvigsson J; Krisky D; Casas R; Battelino T; Castaño L; Greening J; Kordonouri O; Otonkoski T; Pozzilli P; Robert JJ; Veeze HJ; Palmer J; Samuelsson U; Elding Larsson H; Åman J; Kärdell G; Neiderud Helsingborg J; Lundström G; Albinsson E; Carlsson A; Nordvall M; Fors H; Arvidsson CG; Edvardson S; Hanås R; Larsson K; Rathsman B; Forsgren H; Desaix H; Forsander G; Nilsson NÖ; Åkesson CG; Keskinen P; Veijola R; Talvitie T; Raile K; Kapellen T; Burger W; Neu A; Engelsberger I; Heidtmann B; Bechtold S; Leslie D; Chiarelli F; Cicognani A; Chiumello G; Cerutti F; Zuccotti GV; Gomez Gila A; Rica I; Barrio R; Clemente M; López Garcia MJ; Rodriguez M; Gonzalez I; Lopez JP; Oyarzabal M; Reeser HM; Nuboer R; Stouthart P; Bratina N; Bratanic N; de Kerdanet M; Weill J; Ser N; Barat P; Bertrand AM; Carel JC; Reynaud R; Coutant R; Baron S
    N Engl J Med; 2012 Feb; 366(5):433-42. PubMed ID: 22296077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined T regulatory cell and Th2 expression profile identifies children with cow's milk allergy.
    Savilahti EM; Karinen S; Salo HM; Klemetti P; Saarinen KM; Klemola T; Kuitunen M; Hautaniemi S; Savilahti E; Vaarala O
    Clin Immunol; 2010 Jul; 136(1):16-20. PubMed ID: 20227920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
    Danke NA; Yang J; Greenbaum C; Kwok WW
    J Autoimmun; 2005 Dec; 25(4):303-11. PubMed ID: 16249070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies.
    Oling V; Marttila J; Knip M; Simell O; Ilonen J
    Ann N Y Acad Sci; 2007 Jun; 1107():363-72. PubMed ID: 17804564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
    Wherrett DK; Bundy B; Becker DJ; DiMeglio LA; Gitelman SE; Goland R; Gottlieb PA; Greenbaum CJ; Herold KC; Marks JB; Monzavi R; Moran A; Orban T; Palmer JP; Raskin P; Rodriguez H; Schatz D; Wilson DM; Krischer JP; Skyler JS;
    Lancet; 2011 Jul; 378(9788):319-27. PubMed ID: 21714999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
    Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
    Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GAD-treatment of children and adolescents with recent-onset type 1 diabetes preserves residual insulin secretion after 30 months.
    Ludvigsson J; Chéramy M; Axelsson S; Pihl M; Akerman L; Casas R;
    Diabetes Metab Res Rev; 2014 Jul; 30(5):405-14. PubMed ID: 24302596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
    Li A; Ojogho O; Franco E; Baron P; Iwaki Y; Escher A
    Vaccine; 2006 Jun; 24(23):5036-46. PubMed ID: 16621191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.
    Gauvrit A; Debailleul M; Vu AT; Sai P; Bach JM
    Clin Exp Immunol; 2004 Aug; 137(2):253-62. PubMed ID: 15270841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.